Oculus Innovative Sciences Reports Revenues of $3.5 Million for the Third Quarter of Fiscal 2013

[at noodls] – Oculus board of directors unanimously approved a plan to spin off the company’s novel drug RUT58-60 as a separate company to be called Ruthigen, Inc. in January 2013 Oculus’ subsidiary, Ruthigen, to pursue … more

View todays social media effects on OCLS

View the latest stocks trending across Twitter. Click to view dashboard

See who Oculus is hiring next, click here to view